B
Eli Lilly and Company LLY
$757.39 $25.603.50% NYSE
Recommendation
Prev Close
$757.39
Volume
4,645,121
Avg Vol (90D)
4,099,158
Market Cap
$679.94B
Dividend & Yield
$5.60(0.74%)
52-Week Range
$677.09 - $972.53
P/E (TTM)
61.62
EPS (TTM)
$12.29
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Is It Time to Buy the Dip in Novo Nordisk Stock?
5/15/2025 - MarketBeat
TrinityPoint Wealth LLC Sells 89 Shares of Eli Lilly and Company (NYSE:LLY)
5/18/2025 - Ticker Report
Strive Asset Management LLC Acquires Shares of 598 Eli Lilly and Company (NYSE:LLY)
5/18/2025 - Ticker Report
Eli Lilly and Company (NYSE:LLY) Shares Bought by Strategic Wealth Partners Ltd.
5/18/2025 - Ticker Report
Toronto Dominion Bank Has $146.98 Million Stock Holdings in Eli Lilly and Company (NYSE:LLY)
5/18/2025 - MarketBeat
Scissortail Wealth Management LLC Has $454,000 Position in Eli Lilly and Company (NYSE:LLY)
5/18/2025 - MarketBeat
Huge News for Eli Lilly Stock Investors!
5/18/2025 - Fool.com Headlines
Why Is Eli Lilly Stock Crashing and Is It a Buying Opportunity?
5/18/2025 - Fool.com Headlines
Eli Lilly and Co (LLY): Expands Genetic Hearing Loss Pipeline with $1.3B RNA Therapy Partnership
5/17/2025 - Insider Monkey
Eli Lilly and Co (LLY): Expands Genetic Hearing Loss Pipeline with $1.3B RNA Therapy Partnership
5/17/2025 - Yahoo! Finance: News
Eli Lilly (LLY) Endowment Now Leads Global Foundations
5/17/2025 - GuruFocus
Top Pharmaceutical Stocks To Research - May 16th
5/17/2025 - MarketBeat
Zepbound, Mounjaro sales buoy Eli Lilly family endowment
5/17/2025 - SeekingAlpha.com: All News
Zepbound, Mounjaro sales buoy Eli Lilly family endowment
5/17/2025 - Seeking Alpha - Healthcare
Eli Lilly and Company (NYSE:LLY) Trading Up 2.3% - Still a Buy?
5/17/2025 - MarketBeat
Promising Medical Stocks To Watch Now - May 16th
5/17/2025 - MarketBeat
Rep. Julie Johnson Sells Eli Lilly and Company (NYSE:LLY) Shares
5/17/2025 - MarketBeat
Safeguard Investment Advisory Group LLC Grows Holdings in Eli Lilly and Company (NYSE:LLY)
5/17/2025 - Ticker Report
Eli Lilly and Company (NYSE:LLY) Shares Sold by Snowden Capital Advisors LLC
5/17/2025 - MarketBeat
Shell Asset Management Co. Decreases Holdings in Eli Lilly and Company (NYSE:LLY)
5/17/2025 - MarketBeat
Sig Brokerage LP Invests $452,000 in Eli Lilly and Company (NYSE:LLY)
5/17/2025 - MarketBeat
Point72 Europe London LLP Purchases Shares of 1,045 Eli Lilly and Company (NYSE:LLY)
5/17/2025 - MarketBeat
FDA Clears First Blood Test To Help Diagnose Alzheimer's Disease
5/17/2025 - Slashdot
Eli Lilly: Obesity Drug Development To Go Beyond That Of Zepbound
5/16/2025 - Seeking Alpha - Long Ideas
Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
5/6/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$49.00B
EBITDA (TTM)
$22.00B
EBIT (TTM)
$20.17B
Net Income (TTM)
$11.11B
Balance Sheet
Total Assets (Q)
$89.39B
Total Debt (Q)
$38.60B
Total Liabilities (Q)
$73.54B
Book Value Per Share (Q)
$16.64
Cash Flow
Cash from Operations (TTM)
$9.32B
Cash from Investing (TTM)
-$11.48B
Cash from Financing (TTM)
$2.92B
Net Change in Cash (TTM)
$633.10M
Filings
Filing Date
Thursday, May 1, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
0.89
7-Day Total Return
0.79%
30-Day Total Return
2.60%
60-Day Total Return
-13.34%
90-Day Total Return
-2.06%
Year to Date Total Return
-2.66%
1-Year Total Return
-1.65%
2-Year Total Return
74.03%
3-Year Total Return
154.98%
5-Year Total Return
401.61%
52-week Low
Apr 07, 2025 - $677.09
52-week High
Aug 22, 2024 - $972.53
Valuation
Market Cap
$679.94B - Mega Cap
Enterprise Value
$714.94B
Price/Sales (TTM)
13.92
Price/Book (Q)
45.53
Dividends and Shares
Shares Outstanding
900.60M
Dividend Per Share (Most Recent)
$1.50
Dividend Per Share (TTM)
$5.60
Corporate Info
Website
www.lilly.com
Phone Number
317 276 2000
Address
Lilly Corporate Center
Indianapolis, IN 46285
Country
United States
Year Founded
1876
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix... more
NYSE 05/16/2025 4:00PM Eastern Quotes delayed